1-7 of 7
Lukas Smolej, M.D., Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Fate of Chronic Lymphocytic Leukemia Patients After Failure of Fludarabine, Cyclophosphamide, and Rituximab Regimen

Anna Panovska, MD, Daniel Lysák, MD, Lukas Smolej, M.D., Ph.D., Yvona Brychtova, M.D., Ph.D., Martin Simkovic, MD, Monika Motyckova, M.D., Michaela Lindtnerova, MD, Martin Trbusek, PhD, Jitka Malcikova, Dr, PhD, Sarka Pospisilova, Prof., Jiri Mayer, M.D., PhD., Prof., Michael Doubek, M.D., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 4603.
https://doi.org/10.1182/blood.V120.21.4603.4603
Published: 2012
Journal Articles

The Detection of Viral Infection in Bronchoalveolar Lavage Samples Collected From Recipients of Allogeneic Haematological Stem Cell Transplantation with Pneumonia (A 3 Year Epidemiological Study 2008–2010)

Eva Stepanova, Jr., MD, Pavel Zak, MD, PhD, Alzbeta Zavrelova, MD, Melanie Cermanova, MD, PHD, Jakub Radocha, MD, Lenka Pliskova, Sr., MD, Vlasta Stepanova, MD, Lukas Smolej, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 4577.
https://doi.org/10.1182/blood.V118.21.4577.4577
Published: 2011
Journal Articles

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

David Warren Hardekopf, Tereza Jancuskova, Marie Jarosova, Lucie Krutilkova, Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, Jan Vydra, Tomas Kozak, MD, PhD, Michal Karas, Vladimir Koza, MD, Alzbeta Zavrelova, MD, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova
Journal: Blood
Blood (2011) 118 (21): 4905.
https://doi.org/10.1182/blood.V118.21.4905.4905
Published: 2011
Journal Articles

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, David Warren Hardekopf, Tereza Jancuskova, Lucie Krutilkova, Michal Karas, Vladimir Koza, MD, Jan Vydra, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova
Journal: Blood
Blood (2011) 118 (21): 2526.
https://doi.org/10.1182/blood.V118.21.2526.2526
Published: 2011
Journal Articles

Correlations Between Ofatumumab Exposure and Treatment Outcomes for Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Ofatumumab, Fludarabine, and Cyclophosphamide Chemoimmunotherapy

William G. Wierda, MD, PhD, Roxanne C. Jewell, PhD, Thomas J. Kipps, M.D., Ph.D, Jan Dürig, MD, Laimonas Griskevicius, Stephan Stilgenbauer, MD, Lukas Smolej, M.D., Ph.D., Georg Hess, Francisco J. Hernandez-Ilizaliturri, MD, Swaminathan Padmanabhan, MBBS, MD, Lei Fang, Michele M. Gorczyca, MS, Geoffrey W. Chan, MD, Ira V. Gupta, MD, Steen Lisby
Journal: Blood
Blood (2011) 118 (21): 1793.
https://doi.org/10.1182/blood.V118.21.1793.1793
Published: 2011
Journal Articles

Low-Dose Fludarabine and Cyclophosphamide Combined with Rituximab In the Treatment of Elderly/Comorbid Patients with chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Preliminary Results of Project Q-Lite by Czech CLL Study Group

Lukas Smolej, M.D., Ph.D., Martin Spacek, M.D., Yvona Brychtova, MD, David Belada, M.D., Ph.D., Jiri Schwarz, M.D., Ph.D., Michael Doubek, MD, PhD, Monika Motyckova, M.D., Eduard Cmunt, M.D., Ph.D., Peter Rohon, MD, Katerina Klaskova, M.S., Tomas Kozak, M.D., Ph.D.
Journal: Blood
Blood (2010) 116 (21): 2466.
https://doi.org/10.1182/blood.V116.21.2466.2466
Published: 2010
Journal Articles

Rituximab In Combination with High-Dose Dexamethasone: An Effective Treatment Option for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Michael Doubek, MD, PhD, Martin Simkovic, MD, Anna Panovska, MD, Monika Hrudkova, MD, David Belada, MD, PhD, Yvona Brychtova, MD, Jiri Mayer, MD, PhD, Lukas Smolej, M.D., Ph.D.
Journal: Blood
Blood (2010) 116 (21): 4629.
https://doi.org/10.1182/blood.V116.21.4629.4629
Published: 2010